CIK 0001159036
- Large accelerated filer
HALOZYME THERAPEUTICS, INC.
Sign in to watch- Ticker
- HALO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 880488686
- Phone
- +1 858-794-8889
- Business address
- 12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
- Former names
- HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $21,662,139
- in 5 filings, $21.7M under 10b5-1 plans
Net −$21,662,139. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-27 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Sale 10b5-1 | −2,984 | $49.55 | $148K | 141,911 |
| 2023-02-27 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Exercise or conversion · Option to Purchase Common Stock 10b5-1 | −2,984 | 37,505 | ||
| 2023-02-27 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Sale | −7,016 | $49.55 | $348K | 141,911 |
| 2023-02-27 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Sale | −2,984 | $49.55 | $148K | 138,927 |
| 2023-02-16 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Exercise or conversion | +6,112 | 151,805 | ||
| 2023-02-16 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Sale | −2,878 | $49.26 | $142K | 148,927 |
| 2023-02-16 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Exercise or conversion · Restricted Stock Units | −6,112 | 18,336 | ||
| 2023-02-16 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Grant or award · Option to Purchase Common Stock | +48,849 | 48,849 | ||
| 2023-02-16 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Grant or award · Restricted Stock Units | +17,053 | 17,053 | ||
| 2023-02-16 | Snyder Mark Howard SVP, GENERAL COUNSEL | Grant or award · Option to Purchase Common Stock | +54,955 | 54,955 | ||
| 2023-02-16 | Snyder Mark Howard SVP, GENERAL COUNSEL | Grant or award · Restricted Stock Units | +19,184 | 19,184 | ||
| 2023-02-16 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Exercise or conversion | +5,094 | 11,591 | ||
| 2023-02-16 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Sale | −2,525 | $49.26 | $124K | 9,066 |
| 2023-02-16 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Exercise or conversion · Restricted Stock Units | −5,094 | 15,279 | ||
| 2023-02-16 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Grant or award · Option to Purchase Common Stock | +61,061 | 61,061 | ||
| 2023-02-16 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Grant or award · Restricted Stock Units | +21,316 | 21,316 | ||
| 2023-02-16 | Torley Helen PRESIDENT AND CEO | Exercise or conversion | +21,010 | 644,727 | ||
| 2023-02-16 | Torley Helen PRESIDENT AND CEO | Sale | −11,061 | $49.26 | $545K | 633,666 |
| 2023-02-16 | Torley Helen PRESIDENT AND CEO | Exercise or conversion · Restricted Stock Units | −21,010 | 63,027 | ||
| 2023-02-16 | Torley Helen PRESIDENT AND CEO | Grant or award · Option to Purchase Common Stock | +193,360 | 193,360 |
Page 40 of 48 · 944 trades